BRCA2 and ovarian carcinoma: RAD51C mutations have previously been reported to increase the risk for breast and ovarian cancer and to also be causative for a recessively inherited Fanconi anemia-like disorder [25], similar to BRCA1, BRCA2 and PALB2 mutations.